Neuroimaging in Bipolar Disorder

Öz

Bipolar disorder is characterized by recurrent attacks, significantly disrupts the functionality of a chronic mental disorder. Although there is growing number of studies on the neurobiological basis of the disorder, the pathophysiology has not yet been clearly understood. Structural and functional imaging techniques present a better understanding of the etiology of bipolar disorder and has contributed significantly to the development of the diagnostic approach. Recent developments in brain imaging modalities have let us learn more about the underlying abnormalities in neural systems of bipolar patients. Identification of objective biomarkers would help to determine the pathophysiology of bipolar disorder, a disorder which causes significant deterioration in neurocognitive and emotional areas.

Anahtar Kelimeler

• Bipolar disorder, neuroimaging, neurobiology

Bipolar Bozuklukta Nörogörüntüleme

Öz

Bipolar bozukluk tekrarlayan ataklarla seyreden, işlevselliği belirgin olarak bozan kronik bir ruhsal bozukluktur. Nörobiyolojik temelleri olan hastalıkla ilgili birçok çalışma yapılmasına rağmen patofizyolojisi tam olarak bilinmemektedir. Yapısal ve işlevsel görüntüleme tekniklerinin, bipolar bozukluğun etyolojisinin daha iyi anlaşılmasına ve tanısal yaklaşımının gelişmesine belirgin katkısı olmuştur. Beyin görüntüleme modalitelerindeki güncel gelişmeler sayesinde hastalığın altında yatan nöral sistemlerdeki anormallikler hakkında bilinenler artmaktadır. Nörobilişsel ve duygusal alanlarda belirgin bozulma olan bu hastalıkta, nesnel biyobelirteçlerin tanımlanması bozukluğun patofizyolojisini aydınlatmakta fayda sağlayacaktır.

Anahtar Kelimeler

• Bipolar bozukluk, nörogörüntüleme, nörobiyoloji

Kaynakça

1. Phillips ML, Vieta E. Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr Bull 2007; 33:893-904.
2. Singh I, Rose N. Biomarkers in psychiatry. Nature 2009; 460:202-207.
3. Blumberg HP, Charney DS, Krystal JH. Frontotemporal neural systems in bipolar disorder. Semin Clin Neuropsychiatry 2002; 7;243-254.
4. Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception II:implications for major psychiatric disorders. Biol Psychiatry 2003; 54:515-528.
5. Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 2008; 13:833-857.
6. Houenou J, Frommberger J, Carde S, Glasbrenner M, Diener C, Leboyer M et al. Neuroimaging-based markers of bipolar disorder: evidence from two meta-analyses. J Affect Disord 2011; 132:344-355.
7. Ellison-Wright I, Bullmore E. Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res. 2010; 117:1-12.
8. Bora E, Fornito A, Yücel M. Voxelwise meta-analysis of grey matter abnormalities in bipolar disorder. Biol Psychiatry 2010; 67:1097-1105.

9. Fountoulakis KN, Giannakopoulos P, Kovari E. Assessing the role of cingulate cortex in bipolar disorder: neuropathological, structural and functional imaging data. Brain Res Rev 2008; 59:9-21.
10. Bruno SD, Barker GJ, Cercignani M, Symms M, Ron MA. A study of bipolar disorder using magnetization transfer imaging and voxel-based morphometry. Brain 2004; 127:2433-2440.
11. McDonald C, Bullmore ET, Sham PC, Chitnis X, Wickham H, Bramon E et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004; 61:974-984.
12. McIntosh AM, Job DE, Moorhead TW, Harrison LK, Lawrie SM, Johnstone EC. White matter density in patients with schizophrenia, bipolar disorder and their unaffected relatives. Biol Psychiatry 2005; 58:254-257.
13. Stanfield AC, Moorhead TW, Job DE, McKirdy J, Sussmann JE, Hall J et al. Structural abnormalities of ventrolateral and orbitofrontal cortex in patients with familial bipolar disorder. Bipolar Disord 2009;11:135-144.
14. Beyer JL, Young R, Kuchibhatla M, Krishnan KR. Hyperintense MRI lesions in bipolar disorder: a meta-analysis and review. Int Rev Psychiatry 2009; 21:394-409. Kempton MJ, Geddes JR, Ettinger U Williams SC, Grasby PM. Meta-analysis, database,and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008; 65:1017-10132.
15. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry 2006; 60:93-105.
16. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4:469-480.
17. Vederine FE, Wessa M, Leboyer M, Houenou J. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:1820-1826.
18. Wessa M, Linke J. Emotional processing in bipolar disorder: behavioural and neuroimaging findings. Int Rev Psychiatry 2009; 21:357-367.
19. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004; 61:450-458.
20. Cecil KM, DelBello MP, Morey R, Strakowski SM. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 2002; 4:357-365.
21. Dixon JF, Hokin LE. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. Proc Natl Acad Sci U.S.A 1997; 94:4757-4760.
22. Dixon JF, Hokin LE. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci U.S.A 1998; 95:8363-8368.
23. Öngür D, Jensen JE, Prescot AP, Stork C, Lundy M, Cohen BM et al. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry 2008; 64:718-726.
24. Port JD, Unal SS, Mrazek DA, Marcus SM. Metabolic alterations in medication-free patients with bipolar disorder: A 3T CSF-corrected magnetic resonance spectroscopic imaging study. Psychiatr Res 2008; 162:113-121.
25. Bruno SD, Papadopoulou K, Cercignani M, Cipolotti L, Ron MA. Structural brain correlates of IQ changes in bipolar disorder. Psychol Med 2006; 36:609-618.
26. Damasio AR. Neuropsychology. Towards a neuropathology of emotion and mood. Nature 1997; 386:769-770.
27. Bhardwaj R, Chakrabarti S, Mittal BR, Sharan P. Single photon emission computerized tomography (SPECT) study of regional cerebral blood flow in bipolar disorder.World J Biol Psychiatry 2010; 11:334-343.
28. Drevets WC, Price JL, Bardgett ME, Reich T, Todd RD, Raichle ME. Glucose metabolism in the amygdala in depression:relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 2002; 71:431-447.
29. Mah L, Zarate CA Jr, Singh J, Duan YF, Luckenbaugh DA, Manji HK et al. Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biol Psychiatry 2007; 61:765-775.
30. Blumberg HP, Stern E, Martinez D, Ricketts S, de Asis J, White T et al. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiatry 2000; 48:1045-1052.
31. Kruger S, Seminowicz D, Goldapple K, Kennedey SH, Mayberg HS. State and trait influences on mood regulation in bipolar disorder: blood flow differences with an acute mood challenge. Biol Psychiatry 2003; 54:1274-1283.
32. Rubinsztein JS, Fletcher PC, Rogers RD, Ho LW, Aigbirhio FI, Paykel ES et al. Decision making in mania: a PET study. Brain 2001; 124:2550-2563.
33. Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE et al. Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 2001; 49:97-109.
34. Zhang L, Li CT, Su TP, Hu XZ, Lanius RA, Webster MJ et al. P11 expression and PET in bipolar disorders. J Psychiatr Res 2011; 45:1426-1431.
35. Yatham LN, Liddle PF, Erez J, Kauer-Sant'Anna M, Lam RW, Imperial M et al. Brain serotonin-2 receptors in acute mania. Br J Psychiatry 2010; 196:47-51.
36. Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY et al. Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biol Psychiatry 2009; 66:223-230.
37. Sargent PA, Rabiner EA, Bhagwagar Z, Clark L, Cowen P, Goodwin GM et al. 5HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-(11)C]WAY-100635. J Affect Disord 2010; 123:77-80. Anand A, Barkay G, Dzemidzic M, Albrecht D, Karne H, Zheng QH et al. Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord 2011; 13:406-413.
38. Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK et al. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biol Psychiatry 2006; 60:207-217.
39. Hafeman DM, Chang KD, Garrett AS, Sanders EM, Phillips ML et al. Effects of medication on neuroimaging findings in bipolar disorder: an updated review. Bipolar Disord 2012; 14:375-410.
40. Pavuluri MN, Passarotti AM, Harral EM, Sweeney JA. Enhanced prefrontal function with pharmacotherapy on a response inhibition task in adolescent bipolar disorder. J Clin Psychiatry 2010; 71:1526-1534.
41. Pavuluri MN, Passarotti AM, Parnes SA Fitzgerald JM, Sweeney JA. A pharmacological functional magnetic resonance imaging study probing the interface of cognitive and emotional brain systems in pediatric bipolar disorder. J Child Adolesc Psychopharmacol 2010; 20:395-406.
42. Jogia J, Haldane M, Cobb A, Kumari V, Frangou S. Pilot investigation of the changes in cortical activation during facial affect recognition with lamotrigine monotherapy in bipolar disorder. Br J Psychiatry 2008; 192:197-201.
43. Chang K, Karchemskiy A, Kelley R, Howe M, Garrett A, Adleman N et al. Effect of divalproex on brain morphometry, chemistry, and function in youth at high-risk for bipolar disorder: a pilot study. J Child Adolesc Psychopharmacol 2009; 19:51-59.
44. Chang KD, Wagner C, Garrett A, Home M, Reiss A. A preliminary functional magnetic resonance imaging study of prefrontal-amygdalar activation changes in adolescents with bipolar depression treated with lamotrigine. Bipolar Disord 2008; 10:426-431.
45. Wang F, Kalmar JH, He Y, Jackowski M, Chepenik LG, Edmiston EE et al. Functional and structural connectivity between the perigenual anterior cingulate and amygdala in bipolar disorder. Biol Psychiatry 2009; 66:516-521.
46. Versace A, Almeida JR, Quevedo K, Thompson WK, Terwilliger RA, Hassel S et al. Right orbitofrontal corticolimbic and left corticocortical white matter connectivity differentiate bipolar and unipolar depression. Biol Psychiatry 2010; 68:560-567.
47. Zanetti MV, Jackowski MP, Versace A, Almeida JR, Hassel S, Duran FL et al. State dependent microstructural white matter changes in bipolar I depression. Eur Arch Psychiatry Clin Neurosci 2009; 259:316-328.
48. Barnea-Goraly N, Chang KD, Karchemskiy A, Howe ME, Reiss AL. Limbic and corpus callosum aberrations in adolescents with bipolar disorder: a tract-based spatial statistics analysis. Biol Psychiatry 2009; 66:238-244.
49. Chaddock CA, Barker GJ, Marshall N, Schulze K, Hall MH, Fern A et al. White matter microstructural impairments and genetic liability to familial bipolar I disorder. Br J Psychiatry 2009; 194:527-534.
50. Wang F, Kalmar JH, Edmiston E, Chepenik LG, Bhagwagar Z, Spencer L et al. Abnormal corpus callosum integrity in bipolar disorder: a diffusion tensor imaging study. Biol Psychiatry 2008; 64:730-733.
51. McIntosh AM, Munoz Maniega S, Lymer GK, McKirdy J, Hall J, Sussmann JE et al. White matter tractography in bipolar disorder and schizophrenia. Biol Psychiatry 2008; 64:1088-1092.
52. Wang F, Jackowski M, Kalmar JH, Chepenik LG, Tie K, Qiu M et al. Abnormal anterior cingulum integrity in bipolar disorder determined through diffusion tensor imaging. Br J Psychiatry 2008; 193:126-129.
53. Frazier JA, Breeze JL, Papadimitriou G, Kennedy DN, Hodge SM, Moore CM et al. White matter abnormalities in children with and at risk for bipolar disorder. Bipolar Disord 2007; 9:799-809.
54. Wessa M, Houenou J, Leboyer M, Chanraud S, Poupon C, Martinot JL et al. Microstructural white matter changes in euthymic bipolar patients: a whole-brain diffusion tensor imaging study. Bipolar Disord 2009; 11:504-514.
55. Yurgelun-Todd DA, Silveri MM, Gruber SA, Rohan ML, Pimentel PJ. White matter abnormalities observed in bipolar disorder: a diffusion tensor imaging study. Bipolar Disord 2007; 9: 504-512.
56. Macritchie KA, Lloyd AJ, Bastin ME, Vasudev K, Gallagher P, Eyre R et al. White matter microstructural abnormalities in euthymic bipolar disorder. Br J Psychiatry 2010; 196:52-58.
57. Sussmann JE, Lymer GKS, McKirdy J, Moorhead TW, Muñoz Maniega S, Job D et al. White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging. Bipolar Disord 2009; 11:11-18.
58. Karababa İF, Çiçek E, Çiçek İE, Kayhan F, Aşkın R. Bipolar–I bozukluğu olan hastalarda klinik özellikler ile hastalığın seyri arasındaki ilişki. Selçuk Tıp Dergisi 2012; 28:9Rich BA, Schmajuk M, Perez-Edgar KE, Pine DS, Fox NA, Leibenluft E. The impact of reward, punishment, and frustration on attention in pediatric bipolar disorder. Biol Psychiatry 2005; 58:532-539.
59. Birmaher B, Axelson D, Strober M, Gill MK, Valeri S, Chiappetta L et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry 2006; 63:175-183.
60. Demirel A, Demirel ÖF, Kadak MT, Duran A. Ötimik bipolar hastalarda nörobilişsel defisitler. Psikiyatride Güncel Yaklaşımlar 2012; 4:381-395.
61. Blumberg HP, Martin A, Kaufman J, Leung HC, Skudlarski P, Lacadie C et al. Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am J Psychiatry 2003;7:1345-1347.
62. McClure EB, Treland JE, Snow J, Schmajuk M, Dickstein DP, Towbin KE et al. Deficits in social cognition and response flexibility in pediatric bipolar disorder. Am J Psychiatry 2005;162:1644-1651.
63. Dickstein DP, Milham MP, Nugent AC, Drevets WC, Charney DS, Pine DS et al. Frontotemporal alterations in pediatric bipolar disorder:results of a voxel-based morphometry study. Arch Gen Psychiatry 2005; 62:734-741.
64. Chang K, Adleman NE, Dienes K, Simeonova DI, Menon V, Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Arch Gen Psychiatry 2004; 61:781-792. Blumberg HP, Fredericks C, Wang F, Kalmar JH, Spencer L, Papademetris X et al. Preliminary evidence for persistent abnormalities in amygdala volumes in adolescents and young adults with bipolar disorder. Bipolar Disord 2005; 7:570-576.
65. Chen BK, Sassi R, Axelson D, Hatch JP, Sanches M, Nicoletti M et al. Crosssectional study of abnormal amygdala development in adolescents and young adults with bipolar disorder. Biol Psychiatry 2004; 56:399-405.
66. Blumberg HP, Krystal JH, Bansal R, Martin A, Dziura J, Durkin et al. Age, rapidcycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry 2006; 59:611-618. Kemal Kara, Uzm. Dr., Beytepe Asker Hastanesi, Ankara; Samet Verim, Uzm. Dr., Ankara Mevki Asker Hastanesi, Ankara; Süleyman Akarsu, Dr., GATA, Ankara . Yazışma Adresi/Correspondence: Kemal Kara, Beytepe Asker Hastanesi, Ankara, Turkey. E-mail: [e-mail] Yazarlar bu makale ile ilgili herhangi bir çıkar çatışması bildirmemişlerdir. The authors reported no conflict of interest related to this article. Çevrimiçi adresi / Available online at: www.cappsy.org/archives/vol5/no1/ Çevrimiçi yayım / Published online 28 Ekim/October 28, 2012; doi:10.5455/cap.20130501